Further analysis of Siglec-7+ CD8+ T cells isolated from the bone marrow of four AML patients revealed co-expression with CTLA4, and, to a lesser extent with other check-point receptors, such as PD1, LAG3, BTLA, TIM3 (Figure 6G). This evidence concerns the gene HAVCR2 and acute myeloid leukemia.